allogeneic blood cells

Cell therapyexperimental

Blood is a body fluid in the circulatory system of humans and other vertebrates that delivers necessary substances such as nutrients and oxygen to the cells, and transports metabolic waste products away from those same cells. — Wikipedia

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • allogeneic blood
  • allogeneic blood cells
  • allogeneic white blood cells
  • blood
  • blood
  • blood products
  • donor pbsc

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06938789N/AApr 30, 2025Aarhus University, Gødstrup Hospital
NCT07066072N/ADec 1, 2022Cairo University
NCT05290545Phase 3Feb 15, 2022First People's Hospital of Chenzhou, Guangzhou Medical University, Southern Medical University, Sun Yat-Sen University, University of Science and Technology of China
NCT04750070Phase 3Oct 31, 2021International Center for Diarrheal Disease Research, Muhimbili University, University of British Columbia
NCT04879485N/AMay 3, 2021Aarhus University, Danish Research Foundation, Copenhagen, Norwegian Air Ambulance Foundation, University of Southern Denmark
NCT04642274N/AJan 1, 2021Fudan University
NCT04383756Early Phase 1 (Phase 1)Jul 31, 2020Vanderbilt University
NCT04098770Phase 2Oct 1, 2019People's Liberation Army of China
NCT03548766Phase 3Oct 31, 2018Anti-Doping Lab Qatar, Hamad Medical Corporation, Laboratorio Antidoping FMSI, Sidra Medical and Research Center, World Anti-doping Agency
NCT03429790N/AMar 1, 2018Wenzhou Medical University
NCT03419780N/AMar 1, 2018University of Pennsylvania
NCT03079089N/AJun 28, 2017Association for Training, Education, and Research in Hematology, Immunology, and Transplantation
NCT03138200N/AMar 8, 2017Medical Centre Hungarian Defence Forces, Szeged University
NCT03292445Early Phase 1 (Phase 1)Feb 14, 2017California Institute for Regenerative Medicine, Stanford University
NCT02990273N/AJan 1, 2017Johns Hopkins University
NCT02731157Phase 4Dec 1, 2016Duke University, University of North Carolina at Chapel Hill
NCT03727230N/AOct 1, 2016Guangzhou Blood Center
NCT02579187Phase 1Sep 1, 2016University of Iowa
NCT02811653N/ADec 31, 2015University of Picardie Jules Verne
NCT02240992Phase 2/Phase 3 (Phase 3)Sep 1, 2014Guangzhou Medical University, Huazhong University of Science and Technology, Peking University, People's Liberation Army of China, Shantou University, Southern Medical University, Sun Yat-Sen University
Showing 20 of 45 trials
Page 1 / 3

Organizations

Research & Development (74)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Aarhus UniversityAcademic/Hospital3322010
National Cancer Institute (NCI)Government3131997
People's Liberation Army of ChinaGovernment3122014
Southern Medical UniversityAcademic/Hospital3322014
Sun Yat-Sen UniversityAcademic/Hospital3022014
Fudan UniversityAcademic/Hospital2122014
Guangzhou Medical UniversityAcademic/Hospital2012014
Peking UniversityAcademic/Hospital2022014
Shantou UniversityAcademic/Hospital2022014
Ain Shams UniversityAcademic/Hospital1112010
Andalusian Initiative for Advanced TherapiesAcademic/Hospital1112011
Andalusian Initiative in Advanced TherapiesGovernment1012011
Anti-Doping Lab QatarAcademic/Hospital1012018
Association for Training, Education, and Research in Hematology, Immunology, and TransplantationAcademic/Hospital1112017
Australian Red CrossAcademic/Hospital1012012
Azienda Ospedaliera San Giovanni BattistaAcademic/Hospital1112013
Cairo UniversityAcademic/Hospital1112022
California Institute for Regenerative MedicineAcademic/Hospital1012017
Columbia UniversityAcademic/Hospital1112012
Cook MedicalFor profit1112013
74 organizations
Page 1 / 4